Member Login
A clinical research consortium sponsored by NIAID and JDRF
about us
news
research
Clinical Trials
Core Facilities
Lab Protocols
Publications
proposals
careers
contact
Clinical Trials
Core Facilities
Lab Protocols
Publications
professionals
> Clinical Trials
Clinical Trials
All
|
Transplantation
|
Autoimmune Diseases
|
Allergy & Asthma
All
|
Islet Transplantation
|
Kidney Transplantation
|
Liver Transplantation
All
|
Lupus
|
Multiple Sclerosis
|
Psoriatic Arthritis
|
Type 1 Diabetes
|
Vasculitis
All
|
Asthma
|
Peanut Allergy
|
Ragweed Allergy
Active
Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children (GPAC) Study
Principal Investigator:
Patrick Holt, University of Western Australia, Perth, AUS
Peter Sly, Telethon Institute for Child Health Research, Perth, AUS
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Promoting Tolerance to Peanut in High-Risk Children (LEAP)
Principal Investigator:
Gideon Lack, Evelina Children's Hospital, London, UK
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Campath-1H/Tacrolimus/Sirolimus Withdrawal in Renal Transplantation
Principal Investigator:
Stuart Knechtle, University of Wisconsin, Madison, WI
[
Details
] [
Clinicaltrials.gov
]
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Principal Investigator:
Flavio Vincenti, University of California, San Francisco, CA
Christian Larsen, MD, Emory University, Atlanta, GA
[
Details
] [
Clinicaltrials.gov
]
Pilot Study Using Donor Stem Cells and Campath-1H to Induce Renal Transplant Tolerance
Principal Investigator:
George W. Burke, University of Miami, FL
[
Details
] [
Clinicaltrials.gov
]
Safety and Efficacy of Campath-1H and Tacrolimus Followed By Immunosuppression Withdrawal in Liver Transplantation
Principal Investigator:
J. Richard Thistlethwaite, University of Chicago, IL
[
Details
] [
Clinicaltrials.gov
]
Gradual Withdrawal of Immunosuppression in Patients Receiving a Liver Transplant (AWISH)
Principal Investigator:
Abraham Shaked, University of Pennsylvania, Philidelphia, PA
[
Details
] [
Clinicaltrials.gov
]
Immunosuppression Withdrawal for Pediatric Living-Donor Liver Transplant Recipients (WISP-R)
Principal Investigator:
Sandy Feng, University of California, San Francisco
[
Details
] [
Clinicaltrials.gov
]
A Phase II study of multiple doses of hOKT3γ-1(Ala-Ala) for new onset type 1 diabetes (AbATE)
Principal Investigator:
Kevan Herold, Yale University, New Haven, CT
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Study of Thymoglobulin to Arrest Type 1 Diabetes (START)
Principal Investigator:
Stephen Gitelman, University of California, San Francisco
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
Atorvastatin (Lipitor) Therapy in Patients With Clinically Isolated Syndrome (CIS) at Risk for Multiple Sclerosis (STAYCIS)
Principal Investigator:
Scott Zamvil, University of California, San Francisco
[
Details
] [
Clinicaltrials.gov
]
Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis (RAVE)
Principal Investigator:
John H. Stone, Johns Hopkins University
Ulrich Specks, Mayo Clinic
[
Details
] [
Clinicaltrials.gov
]
Treatment of psoriatic arthritis with hOKT3γ(Ala-Ala): Psoriatic Arthritis Research Trial (PART)
Principal Investigator:
Marcus Clark, University of Chicago
[
Details
] [
Clinicaltrials.gov
] [
Study Website
]
A Phase I Trial of IL-2 and Sirolimus in Recent-onset Type 1 Diabetes Mellitus
Principal Investigator:
Carla Greenbaum, Virginia Mason Research Center
[
Details
] [
Clinicaltrials.gov
]
ITN Registry of Tolerant Kidney Transplant Recipients
Principal Investigator:
Kenneth Newell, Emory University
[
Details
] [
Study Website
]
Cytokine production in blood leukocytes of prediabetic children and effect of intranasal insulin
Principal Investigator:
Jorma Ilonen, University of Turku, Finland
[
Details
]
Abatacept and Cyclophosphamide Combination: Efficacy and Safety Study (ACCESS) for Lupus Nephritis
Principal Investigator:
David Wofsy, University of California San Francisco, CA
Betty Diamond, Feinstein Institute, Manhasset, NY
[
Details
] [
Clinicaltrials.gov
]
Completed
Efficacy and Safety Evaluation of Allergen Immunotherapy Co-Administered with Omalizumab, an anti-IgE Monoclonal Antibody
Principal Investigator:
Thomas B. Casale, Creighton University School of Medicine
[
Details
] [
Clinicaltrials.gov
]
Allergen ISS conjugates in allergic rhinitis
Principal Investigator:
Peter Creticos, Johns Hopkins University, Baltimore, MA
[
Details
]
Multicenter trial of islet transplantation in type 1 diabetic patients using the Edmonton protocol
Principal Investigator:
James Shapiro, University of Alberta, Edmonton, Canada
[
Details
]
Renal allograft tolerance through mixed chimerism
Principal Investigator:
David H. Sachs, Mass. General Hospital, Boston, MA
A. Benedict Cosimi, Mass. General Hospital, Boston, MA
[
Details
] [
Clinicaltrials.gov
]
Mixed chimerism and Renal Allograft with Non-Myeloablative Conditioning in Patients with ESRD due to Multiple Myeloma
Principal Investigator:
Megan Sykes, Mass. General Hospital, Boston, MA
[
Details
] [
Clinicaltrials.gov
]
Autoantigen vaccination in newly diagnosed type 1 diabetes mellitus
Principal Investigator:
Tihamer Orban, Joslin Diabetes Center, Boston, MA
[
Details
] [
Clinicaltrials.gov
]
Phase I study of the treatment of multiple sclerosis with CTLA4Ig
Principal Investigator:
Samia Khoury, Brigham & Women's Hospital, Boston, MA
[
Details
] [
Clinicaltrials.gov
]